Sertraline
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292016This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C17H17Cl2N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QUC7NX6WMB, chemically known as (1s,4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naphthalenamine but generally known as sertraline, which bears US NIH Compound Identifier 5203. European Medicines Agency schedules Sertraline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10499MIG. The term SERTRALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules sertraline in its Anatomical Therapeutic Chemical (ATC) Classification. SERTRALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sertraline under HS 29214500 and SITC 51454. As of Q4 2014, SERTRALINE remains the US FDA Preferred Term for this commodity. Sertraline bears US NLM identifiers UMLS ID C0074393 and NCI Concept Code C61939. SMILES: Clc1cc(C2CCC(NC)c3c2cccc3)ccc1Cl.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.